Efficacy and Safety at 96 weeks of Bulevirtide 2 mg or 10 mg Monotherapy for Chronic Hepatitis Delta: Results From an Interim Analysis of a Phase 3 Randomized Study - Wedemeyer, Heiner; Aleman, Soo; Brunetto, Maurizia; Blank, Antje; Andreone, Pietro; Bogomolov, Pavel; Chulanov, Vladimir; Mamonova, Nina; Geyvandova, Natalia; Morozov, Viacheslav; Sagalova, Olga; Stepanova, Tatyana; Manuilov, Dmitry; Mercier, Renee-Claude; An, Qi; Flaherty, John F.; Osinusi, Anu; Lau, Audrey; zur Schulze Wiesch, Julian; Cornberg, Markus; Zeuzem, Stefan; Lampertico, Pietro (Zeitschrift für Gastroenterologie, 2024)